
Ivosidenib Improves Survival in Advanced IDH1-Positive Cholangiocarcinoma
Author(s) -
Mark L. Fuerst
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000735084.84586.d5
Subject(s) - medicine , idh1 , isocitrate dehydrogenase , oncology , placebo , cancer , malignancy , gastroenterology , pathology , mutant , biochemistry , gene , chemistry , alternative medicine , enzyme